Cognitive deficits in patients with peripheral vestibular dysfunction.
cognitive deficit
dementia
nonspatial abilities
peripheral vestibulopathy
screening tests
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
04 Jun 2023
04 Jun 2023
Historique:
revised:
24
05
2023
received:
01
03
2023
accepted:
01
06
2023
pubmed:
5
6
2023
medline:
5
6
2023
entrez:
5
6
2023
Statut:
aheadofprint
Résumé
Previous studies demonstrated cognitive deficits in patients with peripheral vestibulopathy (PVP) with dysfunction of spatial navigation and orientation, but also documented cognitive decline in nonspatial abilities. This study evaluates cognitive deficits in patients with unilateral vestibulopathy (UVP) as well as bilateral vestibulopathy (BVP) in multiple cognitive domains using common screening tests to reliably detect these deficits in clinical practice. This prospective study compared patients with UVP and BVP to age- and sex-matched healthy controls (HC). Tests included the Alzheimer's Disease Assessment Scale (ADAS), Mini-Mental Status Examination (MMSE), Trail Making Test Part A and B, Clock Drawing Task, Executive Interview-25 (EXIT25), Dementia Detection (DemTect), and the Judgment of Line Orientation (JLO). The Montgomery-Åsberg Depression Rating Scale was used to control for depression. Videonystagmography objectively reconfirmed PVP. The Vertigo Symptoms Scale and the Dizziness Handicap Inventory were used to assess for symptom severity and restrictions of activities of daily living. Eighty-one patients (65 UVP, 16 BVP) were compared to 55 HC. Patients showed impairment in ADAS, MMSE, DemTect, EXIT25, and JLO. No differences between UVP and BVP were detected. The relative risk (RR) estimates of developing cognitive deficits following PVP were increased. The RR for the ADAS was higher in BVP (RR = 4.91, 95% confidence interval [CI] = 1.87-12.9, p = 0.001) than in UVP (RR = 3.75, 95% CI = 1.65-8.51, p = 0.002), but was similar for the MMSE and DemTect between groups. Patients with PVP showed deficits in multiple cognitive domains including nonspatial cognitive abilities. Vestibulopathy could be a risk factor for the development of cognitive impairment.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Previous studies demonstrated cognitive deficits in patients with peripheral vestibulopathy (PVP) with dysfunction of spatial navigation and orientation, but also documented cognitive decline in nonspatial abilities. This study evaluates cognitive deficits in patients with unilateral vestibulopathy (UVP) as well as bilateral vestibulopathy (BVP) in multiple cognitive domains using common screening tests to reliably detect these deficits in clinical practice.
METHODS
METHODS
This prospective study compared patients with UVP and BVP to age- and sex-matched healthy controls (HC). Tests included the Alzheimer's Disease Assessment Scale (ADAS), Mini-Mental Status Examination (MMSE), Trail Making Test Part A and B, Clock Drawing Task, Executive Interview-25 (EXIT25), Dementia Detection (DemTect), and the Judgment of Line Orientation (JLO). The Montgomery-Åsberg Depression Rating Scale was used to control for depression. Videonystagmography objectively reconfirmed PVP. The Vertigo Symptoms Scale and the Dizziness Handicap Inventory were used to assess for symptom severity and restrictions of activities of daily living.
RESULTS
RESULTS
Eighty-one patients (65 UVP, 16 BVP) were compared to 55 HC. Patients showed impairment in ADAS, MMSE, DemTect, EXIT25, and JLO. No differences between UVP and BVP were detected. The relative risk (RR) estimates of developing cognitive deficits following PVP were increased. The RR for the ADAS was higher in BVP (RR = 4.91, 95% confidence interval [CI] = 1.87-12.9, p = 0.001) than in UVP (RR = 3.75, 95% CI = 1.65-8.51, p = 0.002), but was similar for the MMSE and DemTect between groups.
CONCLUSIONS
CONCLUSIONS
Patients with PVP showed deficits in multiple cognitive domains including nonspatial cognitive abilities. Vestibulopathy could be a risk factor for the development of cognitive impairment.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Heel GmbH
Informations de copyright
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Hülse R, Biesdorf A, Hörmann K, et al. Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals. Otol Neurotol off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2019;40(1):88-95.
Agrawal Y, Smith PF, Rosenberg PB. Vestibular impairment, cognitive decline and Alzheimer's disease: balancing the evidence. Aging Ment Health. 2020;24(5):705-708.
Hitier M, Besnard S, Smith PF. Vestibular pathways involved in cognition. Front Integr Neurosci. 2014;8:59.
Bigelow RT, Semenov YR, Trevino C, et al. Association between visuospatial ability and vestibular function in the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc. 2015;63(9):1837-1844.
Semenov YR, Bigelow RT, Xue Q-L, du Lac S, Agrawal Y. Association between vestibular and cognitive function in U.S. adults: data from the National Health and nutrition examination survey. J Gerontol A Biol Sci Med Sci. 2016;71(2):243-250.
Harun A, Semenov YR, Agrawal Y. Vestibular function and activities of daily living: analysis of the 1999 to 2004 National Health and Nutrition Examination Surveys. Gerontol Geriatr Med. 2015;1:2333721415607124.
Brandt T, Schautzer F, Hamilton DA, et al. Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans. Brain J Neurol. 2005;128(Pt 11):2732-2741.
Kremmyda O, Hüfner K, Flanagin VL, et al. Beyond dizziness: virtual navigation, spatial anxiety and hippocampal volume in bilateral vestibulopathy. Front Hum Neurosci. 2016;10:139.
Popp P, Wulff M, Finke K, Rühl M, Brandt T, Dieterich M. Cognitive deficits in patients with a chronic vestibular failure. J Neurol. 2017;264(3):554-563.
Lucieer FMP, Van Hecke R, van Stiphout L, et al. Bilateral vestibulopathy: beyond imbalance and oscillopsia. J Neurol. 2020;267(Suppl 1):241-255.
Hanes DA, McCollum G. Cognitive-vestibular interactions: a review of patient difficulties and possible mechanisms. J Vestib Res. 2006;16(3):75-91.
Previc FH. Vestibular loss as a contributor to Alzheimer's disease. Med Hypotheses. 2013;80(4):360-367.
Smith PF. The vestibular system and cognition. Curr Opin Neurol. 2017;30(1):84-89.
Bigelow RT, Agrawal Y. Vestibular involvement in cognition: visuospatial ability, attention, executive function, and memory. J Vestib Res Equilib Orientat. 2015;25(2):73-89.
Redfern MS, Talkowski ME, Jennings JR, Furman JM. Cognitive influences in postural control of patients with unilateral vestibular loss. Gait Posture. 2004;19(2):105-114.
Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S13-S21.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
Kalbe E, Kessler J, Calabrese P, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004;19(2):136-143.
Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
Royall DR, Mulroy AR, Chiodo LK, Polk MJ. Clock drawing is sensitive to executive control: a comparison of six methods. J Gerontol B Psychol Sci Soc Sci. 1999;54(5):P328-P333.
Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 1998;64(5):588-594.
Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc. 1992;40(12):1221-1226.
Benton AL, Varney NR, Hamsher KD. Visuospatial judgment. A Clinical Test Arch Neurol. 1978;35(6):364-367.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci. 1979;134:382-389.
Tschan R, Wiltink J, Best C, et al. Validation of the German version of the vertigo symptom scale (VSS) in patients with organic or somatoform dizziness and healthy controls. J Neurol. 2008;255(8):1168-1175.
Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg. 1990;116(4):424-427.
Hüfner K, Hamilton DA, Kalla R, et al. Spatial memory and hippocampal volume in humans with unilateral vestibular deafferentation. Hippocampus. 2007;17(6):471-485.
Péruch P, Lopez C, Redon-Zouiteni C, et al. Vestibular information is necessary for maintaining metric properties of representational space: evidence from mental imagery. Neuropsychologia. 2011;49(11):3136-3144.
Risey J, Briner W. Dyscalculia in patients with vertigo. J Vestib Res Equilib Orientat. 1990 1991;1(1):31-37.
Bigelow RT, Semenov YR, Trevino C, et al. Association between visuospatial ability and vestibular function in the Baltimore longitudinal study of aging. J Am Geriatr Soc. 2015;63(9):1837-1844.
Harun A, Oh ES, Bigelow RT, Studenski S, Agrawal Y. Vestibular impairment in dementia. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2016;37(8):1137-1142.
Kamil RJ, Bilgel M, Wong DF, Resnick SM, Agrawal Y. Vestibular function and Beta-amyloid deposition in the Baltimore longitudinal study of aging. Front Aging Neurosci. 2018;10:408.
McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;13(1):CD005397.
Lindell E, Kollén L, Finizia C. Dizziness symptoms, balance confidence, and vestibular function in older women reporting dizziness and unsteadiness. Otol Neurotol off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2022;43(4):e482-e488.
Obermann M, Bock E, Sabev N, et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol. 2015;262(9):2083-2091.
Prell T, Finn S, Axer H. How healthcare utilization due to dizziness and vertigo differs between older and younger adults. Front Med. 2022;9:852187.
Lacroix E, Deggouj N, Edwards MG, Van Cutsem J, Van Puyvelde M, Pattyn N. The cognitive-vestibular compensation hypothesis: how cognitive impairments might be the cost of coping with compensation. Front Hum Neurosci. 2021;15:732974.